KYNTRA BIO, INC. KYNB 29.3
Health Care · NASDAQ · Data as of 2026-05-12
KYNTRA BIO, INC. (KYNB) has delivered -26.0% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1895 of 1993 stocks overall and #243 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
29.3
Overall Rank
#1895 / 1993
Sector Rank
#243 / 264
Revenue CAGR
-26.0%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio